Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCHW) Other Accumulated Expenses (2023 - 2025)

Historic Other Accumulated Expenses for Envoy Medical (COCHW) over the last 3 years, with Q3 2025 value amounting to $13000.0.

  • Envoy Medical's Other Accumulated Expenses fell 9963.89% to $13000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $13000.0, marking a year-over-year decrease of 9963.89%. This contributed to the annual value of $573000.0 for FY2024, which is 1116.28% down from last year.
  • Envoy Medical's Other Accumulated Expenses amounted to $13000.0 in Q3 2025, which was down 9963.89% from $179000.0 recorded in Q2 2025.
  • In the past 5 years, Envoy Medical's Other Accumulated Expenses ranged from a high of $3.6 million in Q3 2024 and a low of $13000.0 during Q3 2025
  • Moreover, its 3-year median value for Other Accumulated Expenses was $415000.0 (2025), whereas its average is $817857.1.
  • The largest annual percentage gain for Envoy Medical's Other Accumulated Expenses in the last 5 years was 3833.33% (2025), contrasted with its biggest fall of 9963.89% (2025).
  • Over the past 3 years, Envoy Medical's Other Accumulated Expenses (Quarter) stood at $645000.0 in 2023, then dropped by 11.16% to $573000.0 in 2024, then crashed by 97.73% to $13000.0 in 2025.
  • Its Other Accumulated Expenses was $13000.0 in Q3 2025, compared to $179000.0 in Q2 2025 and $415000.0 in Q1 2025.